AI-Powered Psychedelic Treatments: Special Status And Next-Gen Contests Winners
Portfolio Pulse from Lara Goldstein
AI is being used to enhance psychedelic treatments, with companies like Institute of Biomedical Research Corp. (MRES), Cognetivity Neurosciences Ltd. (CGNSF), and Red Light Holland (TRUFF) exploring various applications. AI algorithms are being used to research psychedelic compounds, study cognitive health, and develop 3D movement data for therapy.
June 08, 2023 | 9:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cognetivity Neurosciences has partnered with the Alzheimer's Society in Oman to study cognitive health in patients with dementia and diabetes using its AI-powered Integrated Cognitive Assessment platform.
CGNSF's partnership with the Alzheimer's Society in Oman could lead to advancements in cognitive health research and expand the use of its AI-powered platform, potentially increasing the company's value and attracting investor interest.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
MRES is using AI algorithms to research psychedelic compounds, mainly psilocybin, in collaboration with the University of South Africa.
MRES's use of AI algorithms to research psychedelic compounds could lead to new discoveries and applications in the field, potentially increasing the company's value and attracting investor interest.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Red Light Holland's Radix Motion has been granted 'special' status for its US patent application covering 3D movement data and AI innovations for use in psychedelic-assisted therapy.
TRUFF's Radix Motion's 'special' status for its US patent application could lead to IP protection and further development of its AI innovations in psychedelic-assisted therapy, potentially increasing the company's value and attracting investor interest.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80